Internal Server Error

Peptyde Bio - About the company

Peptyde Bio is an acquired company based in St. Louis (United States), founded in 2021. It operates as a Bio platform innovating nature-positive agriculture through biological technologies for crop health. Peptyde Bio has raised $1.2M in funding from investors like QRM, St. Louis Arch Angels and BioGenerator. The company has 726 active competitors, including 76 funded and 34 that have exited. Its top competitors include companies like Kula Bio, NewLeaf Symbiotics and Fa Bio.

Company Details

Bio platform innovating nature-positive agriculture through biological technologies for crop health. The company develops biological technologies for crop health, enabling farmers to improve yields and use more natural solutions. It focuses on nature-positive solutions by combining new active ingredients with breakthrough delivery systems. The company utilizes an artificial intelligence and machine learning-enabled Discovery Engine to identify targeted biological actives for crop pests and diseases. It also deploys Biological Delivery Systems to improve the performance of actives, ensuring they reach their target and biodegrade quickly. This approach addresses sustainability concerns around traditional crop protection treatments, offering solutions for vegetables, row crops, and perennials. The company is committed to leaving every acre better for future generations, addressing consumer demands and unlocking benefits for farmers and the environment.
Email ID
*****@peptydebio.com
Part Of
Key Metrics
Founded Year
2021
Location
St. Louis, United States
Stage
Acquired
Total Funding
$1.2M in 1 round
Latest Funding Round
Investors
Ranked
Similar Companies
Exit Details
Acquired by Invaio Tech (Dec 07, 2023)

Peptyde Bio's acquisition details

Peptyde Bio got acquired by Invaio Tech on Dec 07, 2023.
Click here to take a look at Peptyde Bio's acquisition in detail
Sign up to download Peptyde Bio's company profile

Peptyde Bio's funding and investors

Peptyde Bio has raised a total funding of $1.2M over 1 round. Its latest funding round was a Seed round on Nov 15, 2022 for $*****. 3 investors participated in its latest round. Peptyde Bio has 4 institutional investors.

Here is the list of recent funding rounds of Peptyde Bio:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Nov 15, 2022
6620966
Seed
1753553
9924612
8605271
7851441
lockAccess funding benchmarks and valuations. Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Peptyde Bio's Competitors and alternates

Top competitors of Peptyde Bio include Kula Bio, NewLeaf Symbiotics and Fa Bio. Here is the list of Top 10 competitors of Peptyde Bio, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Kula Bio
Kula Bio
2018, Natick (United States), Series A
Manufacturer of microbial crop nutrition products
$86.7M
68/100
2nd
Logo for NewLeaf Symbiotics
NewLeaf Symbiotics
2011, St. Louis (United States), Series D
Developer of biological technologies for improved crop input performance
$181M
62/100
3rd
Logo for Fa Bio
Fa Bio
2015, Harpenden (United Kingdom), Series A
Provider of microbes for farming
$10M
60/100
4th
Logo for Ostara
Ostara
2005, Vancouver (Canada), Series C
Manufacturer of sustainable fertilizer products designed to improve crop yields
$174M
58/100
5th
Logo for Pivot Bio
Pivot Bio
2010, Berkeley (United States), Series D
Developer of microbial nitrogen products designed for crop nutrition enhancement
$618M
58/100
6th
Logo for SugaROx
SugaROx
2021, Harpenden (United Kingdom), Seed
Provider of plant sugar-based crop protection solution for farmers
$5.85M
57/100
7th
Logo for BioConsortia
BioConsortia
2014, Davis (United States), Series E
Developer of microbial-based solutions for nitrogen fixation, disease, and nematode control
$56M
57/100
8th
Logo for Locus FS
Locus FS
2014, Solon (United States), Series B
Bio-based solutions enhancing performance across agriculture, industrial, mining, and oil & gas
$250M
56/100
9th
Logo for Groundwork BioAg
Groundwork BioAg
2014, Mazor (Israel), Series B
Developer of mycorrhizal inoculants designed to enhance crop yields and carbon sequestration
$29M
56/100
10th
Logo for Peel Pioneers
Peel Pioneers
2016, Amsterdam (Netherlands), Series A
Manufacturer of ingredients extracted from citrus peels for various applications
$5.85M
55/100
57th
Logo for Peptyde Bio
Peptyde Bio
2021, St. Louis (United States), Acquired
Bio platform innovating nature-positive agriculture through biological technologies for crop health
$1.2M
36/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Peptyde Bio's competitors? Click here to see the top ones

Peptyde Bio's Investments and acquisitions

Peptyde Bio has made no investments or acquisitions yet.

Reports related to Peptyde Bio

Here is the latest report on Peptyde Bio's sector:

News related to Peptyde Bio

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Peptyde Bio

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford